Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 166
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03180957 | Repurposing Anti-TNF for Treating Dupuytren's Disease | ||
| NCT03481725 | Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study | ||
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy | ||
| NCT01260454 | The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain | ||
| NCT05231122 | Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer | ||
| NCT01268553 | Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication | ||
| NCT01028651 | A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension | ||
| NCT04827056 | Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study | ||
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | ||
| NCT01746485 | Three Times Daily Dosing of UT-15C | ||
| NCT05340426 | Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease | ||
| NCT02882126 | An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension | ||
| NCT00325442 | FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT07612488 | A Study of CS231295 in Patients With Advanced Solid Tumors | ||
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | ||
| NCT03804944 | Converting HR+ Breast Cancer Into an Individualized Vaccine | ||
| NCT01767194 | Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma | ||
| NCT03367312 | Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI | ||
| NCT05848687 | TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II | ||
| NCT06580444 | Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study | ||
| NCT00439946 | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH | ||
| NCT03016468 | Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH | ||
| NCT05735249 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | ||
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon | ||
| NCT01302444 | Treprostinil Combined With Tadalafil for Pulmonary Hypertension | ||
| NCT05245006 | PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer | ||
| NCT04868292 | Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers | ||
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | ||
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | ||
| NCT03497689 | EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension | ||
| NCT00069511 | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. | ||
| NCT01353027 | Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus | ||
| NCT03814317 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | ||
| NCT02633293 | An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE | ||
| NCT00760916 | FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT05255991 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT01104870 | A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension | ||
| NCT04084678 | Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects | ||
| NCT01172496 | A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers | ||
| NCT06374459 | Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis | ||
| NCT01043627 | Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) | ||
| NCT01494896 | Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | ||
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours | ||
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | ||
| NCT02279745 | Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension | ||
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | ||
| NCT00741819 | Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects | ||
| NCT02276872 | Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years | ||
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis | ||
| NCT04478071 | Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) |
